Indications and usage

PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery.

Important Safety Information

  • PROLENSA® contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people. In addition, tell your doctor if you have had an allergic reaction to any other medications.
  • Slow or delayed healing may occur while using non-steroidal anti-inflammatory drugs (NSAIDs) such as PROLENSA®.
  • Use of NSAIDs in the eye may result in certain serious eye conditions that can be sight threatening. Tell your doctor immediately about any side effect that you may have.
  • Replace bottle cap after using and do not touch dropper tip to any surface in order to avoid contamination of the bottle.
  • Remove contact lenses prior to using PROLENSA®. The preservative in PROLENSA®, benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes following administration of PROLENSA®.
  • If more than one eye medicine is being used, use the eye medicines at least 5 minutes apart.
  • The most common side effects (seen in 3%-8% of patients) were inflammation of the eye, foreign body sensation, eye pain, light sensitivity, and blurred vision.

Please click here for full Prescribing Information for PROLENSA®.

You are encouraged to report side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

©2025 Bausch + Lomb. All rights reserved. PRA.0020.USA.21 V3.0

All information and materials on this site pertain to the U.S. only, unless otherwise indicated.

Graphic saying Individual Rights Powered by TrustArc